10x Genomics (TXG) shares outstanding

Shares outstanding · fiscal 2025
124.75M

10x Genomics (TXG) had 124.75M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 3.6% higher than the 120.45M of fiscal 2024. Figures as of 18 Nov 2026, 12:29 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Shares outstanding, fiscal 2025
124.75M
Change on fiscal 2024
+3.6%
Growth, 5 years
+4.3% a year
Highest on record
124.75Mfiscal 2025
Lowest on record
39.09Mfiscal 2019
Fiscal years on record
72019–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

10x Genomics shares outstanding, in more detail

The market data feed counts 121.46M shares outstanding today.

Over the five fiscal years to 2025 the diluted share count grew at a compound 4.3% a year. Across the 7 fiscal years on record (2019–2025), the highest was 124.75M in fiscal 2025 and the lowest 39.09M in fiscal 2019.

History · 7 fiscal years

Shares outstanding by fiscal year

10x Genomics shares outstanding, year by year

10x Genomics (TXG) shares outstanding by fiscal year
Fiscal yearShares outstandingChangeYear ended
2025124.75M 3.6% up
2024120.45M 2.8% up
2023117.17M 2.9% up
2022113.86M 3.2% up
2021110.35M 9.1% up
2020101.15M 158.8% up
201939.09M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed.

How to read it

A falling count means buybacks are giving each remaining share a larger slice of the company; a rising one means owners are being diluted.

Shares outstanding at health care companies of similar size

Shares outstanding of 10x Genomics and comparable companies
CompanyShares outstandingFiscal year
Twist Bioscience TWST62.62M2026
Protagonist Therapeutics PTGX63.57M2025
Krystal Biotech KRYS29.95M2025
10x Genomics TXG124.75M2025
Corcept Therapeutics CORT119.99M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on TXG

10x Genomics, figure by figure

10x Genomics (TXG) overview: price, valuation and scorecardAll health care companies by market value

10x Genomics shares outstanding: questions and answers

How many shares does 10x Genomics have?

10x Genomics (TXG) had 124.75M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 3.6% higher than the 120.45M of fiscal 2024. The market data feed counts 121.46M shares outstanding today.

What is the growth rate of 10x Genomics's diluted share count?

Over the five fiscal years to 2025 the diluted share count grew at a compound 4.3% a year.

What are the highest and lowest diluted share count figures on record for 10x Genomics?

Across the 7 fiscal years on record (2019–2025), the highest was 124.75M in fiscal 2025 and the lowest 39.09M in fiscal 2019.

How is 10x Genomics's diluted share count calculated?

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed. For 10x Genomics it is on record here for 7 fiscal years, 2019 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “10x Genomics (TXG) shares outstanding”, data as of 18 November 2026. https://funkfolio.com/stock/TXG/shares-outstanding

Underlying data: the company's filings with the SEC and Yahoo Finance.